Cellenkos is a clinical stage biotech company.
Cellenkos has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Cellenkos's investors include BVCF.
Cellenkos is headquartered in Houston, United States.
Cellenkos is a clinical stage biotech company.
Cellenkos is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellenkos — Funding & Investors." VCBacked, November 4, 2021, https://www.vcbacked.co/company/cellenkos. Accessed August 14, 2026.
VCBacked. (2021). Cellenkos — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cellenkos
{{cite web |title=Cellenkos — Funding & Investors |url=https://www.vcbacked.co/company/cellenkos |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated